KEGG ID: 04720
KEGG Diagram for Long-term potentiation
There are 60 IPI Records from this pathway found in Rattus norvegicus.
Location of Long-term potentiation proteins on Rat Genome
| IPI Record | Position |
|---|---|
| 1: Adcy1_predicted | 14:87812093-87923402 |
| 2: Adcy8 | 7:101957807-102210346 |
| 3: Atf4 | 7:118537666-118538994 |
| 4: Braf | 4:67121585-67243058 |
| 5: Cacna1c | 4:154897217-155517204 |
| 6: Calm3 | 1:77245748-77248702 |
| 7: Camk2a | 18:56879142-56948262 |
| 8: Camk2b | 14:86634690-86721261 |
| 9: Camk2d | 2:224021416-224106433 |
| 10: Camk2g | :- |
| 11: Camk4 | 18:25408043-25626393 |
| 12: Chp | 3:106066389-106101638 |
| 13: Crebbp | 10:11598680-11724122 |
| 14: Gnaq | 1:219520998-219764401 |
| 15: Gria1 | :- |
| 16: Gria2 | 2:172268297-172385156 |
| 17: Grin1 | 3:3453784-3480403 |
| 18: Grin2a | 10:5590487-6004680 |
| 19: Grin2b | 4:172721895-173183187 |
| 20: Grin2c | 10:105323250-105341247 |
| 21: Grin2d | 1:96309508-96342105 |
| 22: Grm1 | 1:5318617-5744593 |
| 23: Grm5 | 1:143863506-144477283 |
| 24: Hras | 1:201385708-201388983 |
| 25: Itpr1 | 4:143705360-144030051 |
| 26: Itpr2 | 4:183679958-184065884 |
| 27: Itpr3 | 20:5292430-5357502 |
| 28: Kras | 4:182869242-182895106 |
| 29: Map2k1 | 8:68379077-68451583 |
| 30: Map2k2 | 7:10074654-10094005 |
| 31: Mapk1 | 11:85968732-86030389 |
| 32: Mapk3 | 1:185935044-185941249 |
| 33: Nras | 2:198292616-198302308 |
| 34: Plcb1 | 3:122799444-123522328 |
| 35: Plcb2 | 3:105197784-105223342 |
| 36: Plcb3 | 1:209628300-209643682 |
| 37: Plcb4 | 3:123861013-124077386 |
| 38: Ppp1ca | 1:206774701-206778330 |
| 39: Ppp1cb | 6:24067538-24099280 |
| 40: Ppp1cc | 12:35580169-35598339 |
| 41: Ppp1r12a | 7:46876642-46985742 |
| 42: Ppp1r1a | 7:142430030-142436247 |
| 43: Ppp3ca | 2:234333405-234408670 |
| 44: Ppp3cb | 15:4003159-4022737 |
| 45: Ppp3cc | 15:50616841-50666010 |
| 46: Ppp3r1 | 14:98047333-98131590 |
| 47: Ppp3r2 | 5:66423374-66424371 |
| 48: Prkaca | 19:25837118-25864844 |
| 49: Prkacb | 2:244946188-245002604 |
| 50: Prkca | 10:97361597-97625118 |
| 51: Prkcb1 | 1:181118102-181459480 |
| 52: Prkcc | 1:64145733-64172745 |
| 53: Raf1 | 4:151752583-151775613 |
| 54: Rap1a | 2:200980324-201058208 |
| 55: Rap1b | 7:57132750-57139811 |
| 56: Rapgef3 | 7:136452870-136474612 |
| 57: RGD1563860_predicted | X:56723492-56827126 |
| 58: Rps6ka1 | :- |
| 59: Rps6ka2 | 1:47424199-47557747 |
| 60: Rps6ka6_predicted | X:99798231-99901585 |
There are 60 IPI Records from this pathway found in Mus musculus.
Location of Long-term potentiation proteins on Mouse Genome
| IPI Record | Position |
|---|---|
| 1: Adcy1 | 11:6963492-7078509 |
| 2: Adcy8 | 15:64528707-64751833 |
| 3: Araf | X:20005537-20017478 |
| 4: Atf4 | 15:80082439-80084794 |
| 5: Braf | 6:39543731-39654902 |
| 6: Cacna1c | 6:118557938-119023135 |
| 7: Calm3 | 12:100601209-100610856 |
| 8: Calm4 | 13:3837002-3837917 |
| 9: Calml3 | 13:3803000-3803449 |
| 10: Camk2a | 18:61050987-61113521 |
| 11: Camk2b | 11:5869675-5965751 |
| 12: Camk2d | 3:126588995-126837076 |
| 13: Camk2g | 14:19523427-19582640 |
| 14: Camk4 | 18:33082366-33311737 |
| 15: Crebbp | 16:3999276-4128632 |
| 16: Gnaq | 19:16199850-16454472 |
| 17: Gria1 | 11:56855457-56858713 |
| 18: Gria2 | 3:80770863-80888718 |
| 19: Grin1 | 2:25114256-25140988 |
| 20: Grin2a | 16:9491382-9906111 |
| 21: Grin2b | 6:135697791-136009994 |
| 22: Grin2c | 11:115065259-115083333 |
| 23: Grin2d | 7:45700822-45734609 |
| 24: Grm1 | 10:10378793-10772495 |
| 25: Grm5 | 7:87477812-88006270 |
| 26: Hras1 | 7:141040427-141045314 |
| 27: Itpr1 | 6:108178895-108516886 |
| 28: Itpr2 | 6:146068634-146459082 |
| 29: Itpr3 | 17:26785125-26849812 |
| 30: Kras | 6:145173866-145207390 |
| 31: Map2k1 | 9:63983787-64051430 |
| 32: Map2k2 | 10:80509092-80527465 |
| 33: Mapk1 | 16:16896945-16961016 |
| 34: Mapk3 | 7:126550780-126556964 |
| 35: Nras | 3:103187290-103196967 |
| 36: Plcb1 | 2:134477974-135163721 |
| 37: Plcb3 | 19:7020758-7036804 |
| 38: Plcb4 | 2:135496989-135704509 |
| 39: Ppp1ca | 19:4192157-4195419 |
| 40: Ppp1cb | 5:32735733-32794014 |
| 41: Ppp1cc | 7:119531075-119533375 |
| 42: Ppp1r12a | 10:107566510-107681685 |
| 43: Ppp1r1a | 15:103359385-103365912 |
| 44: Ppp3ca | 3:136608220-136874773 |
| 45: Ppp3cb | 14:19288592-19335096 |
| 46: Ppp3cc | 14:68953164-69002587 |
| 47: Ppp3r1 | :- |
| 48: Ppp3r2 | 4:49699847-49703083 |
| 49: Prkaca | 8:86863093-86889980 |
| 50: Prkacb | 3:146666960-146750346 |
| 51: Prkca | 11:107754338-108159844 |
| 52: Prkcb1 | 7:122080445-122419803 |
| 53: Prkcc | :- |
| 54: Prkx | X:74014742-74048679 |
| 55: Raf1 | 6:115584217-115642173 |
| 56: Rap1a | 3:105856338-105929392 |
| 57: Rap1b | 10:117217464-117248907 |
| 58: Rapgef3 | 15:97572987-97595706 |
| 59: Rps6ka1 | 4:133119370-133159860 |
| 60: Rps6ka2 | 17:7019773-7152975 |
| 61: Rps6ka3 | X:154600225-154707590 |
| 62: Rps6ka6 | X:107505137-107603726 |
There are 60 IPI Records from this pathway found in Homo sapiens.
Location of Long-term potentiation proteins on Human Genome
| IPI Record | Position |
|---|---|
| 1: ADCY1 | 7:45580646-45729237 |
| 2: ADCY8 | 8:131861736-132123854 |
| 3: ARAF | X:47305460-47316249 |
| 4: ATF4 | 22:38246515-38248637 |
| 5: BRAF | 7:140080754-140271033 |
| 6: CACNA1C | 12:2094650-2670626 |
| 7: CALM3 | 19:51796352-51805878 |
| 8: CALML3 | 10:5555972-5558734 |
| 9: CALML6 | 1:1836126-1838595 |
| 10: CAMK2A | 5:149582736-149649485 |
| 11: CAMK2B | 7:44225422-44331749 |
| 12: CAMK2D | 4:114593022-114902177 |
| 13: CAMK2G | 10:75242265-75304349 |
| 14: CAMK4 | 5:110587968-110858483 |
| 15: CHP | 15:39310729-39361369 |
| 16: CREBBP | 16:3716572-3870723 |
| 17: EP300 | 22:39817736-39905472 |
| 18: GNAQ | 9:79520823-79836194 |
| 19: GRIA1 | 5:152850499-153171354 |
| 20: GRIA2 | 4:158361297-158506677 |
| 21: GRIN1 | 9:139152663-139183028 |
| 22: GRIN2A | 16:9764507-10181769 |
| 23: GRIN2B | 12:13605411-14024319 |
| 24: GRIN2C | 17:70349757-70367602 |
| 25: GRIN2D | 19:53589944-53639205 |
| 26: GRM1 | 6:146390611-146800427 |
| 27: GRM5 | 11:87881006-88420838 |
| 28: HRAS | 11:522243-525572 |
| 29: ITPR1 | 3:4510136-4863432 |
| 30: ITPR2 | 12:26381609-26877347 |
| 31: ITPR3 | 6:33696500-33772329 |
| 32: KRAS | 12:25249449-25295121 |
| 33: MAP2K1 | 15:64466674-64570935 |
| 34: MAP2K2 | 19:4041331-4075126 |
| 35: MAPK1 | 22:20446873-20551730 |
| 36: MAPK3 | 16:30032951-30042116 |
| 37: NRAS | 1:115048613-115102147 |
| 38: PLCB1 | 20:8060908-8813547 |
| 39: PLCB2 | 15:38367402-38387330 |
| 40: PLCB3 | 11:63775623-63791970 |
| 41: PLCB4 | 20:9024932-9409889 |
| 42: PPP1CA | 11:66922228-66925978 |
| 43: PPP1CB | 2:28828118-28926981 |
| 44: PPP1CC | 12:109642127-109665050 |
| 45: PPP1R12A | 12:78692317-78853366 |
| 46: PPP1R1A | 12:53257439-53268723 |
| 47: PPP3CA | 4:102163610-102487376 |
| 48: PPP3CB | 10:74866192-74925765 |
| 49: PPP3CC | 8:22354541-22454580 |
| 50: PPP3R1 | :- |
| 51: PPP3R2 | 9:103393718-103397104 |
| 52: PRKACA | 19:14063509-14089559 |
| 53: PRKACB | 1:84316329-84476769 |
| 54: PRKACG | 9:70817241-70818849 |
| 55: PRKCA | 17:61729388-62237324 |
| 56: PRKCB1 | 16:23754823-24139358 |
| 57: PRKCG | 19:59077279-59102713 |
| 58: PRKX | X:3532415-3641661 |
| 59: PRKY | Y:7202013-7309589 |
| 60: RAF1 | 3:12600108-12680678 |
| 61: RAP1A | 1:111886363-112060836 |
| 62: RAP1B | 12:67290919-67340641 |
| 63: RAPGEF3 | 12:46417307-46439128 |
| 64: RPS6KA1 | 1:26728836-26774108 |
| 65: RPS6KA2 | 6:166742844-167195791 |
| 66: RPS6KA3 | X:20077950-20194671 |
| 67: RPS6KA6 | X:83205640-83329571 |
J Neurosci. 2009 Nov 18; 29(46): 14581-14595
Scimemi A, Tian H, Diamond JS
In the mammalian brain, the specificity of excitatory synaptic transmission depends on rapid diffusion of glutamate away from active synapses and the powerful uptake capacity of glutamate transporters in astrocytes. The extent to which neuronal glutamate transporters influence the lifetime of glutamate in the extracellular space remains unclear. Here we show that EAAC1, the predominant neuronal glutamate transporter at excitatory synapses in hippocampal area CA1, buffers glutamate released during synaptic events and prolongs the time course of its clearance by astrocytes. EAAC1 does not significantly alter activation of receptors in the synaptic cleft. Instead, it reduces recruitment of perisynaptic/extrasynaptic NR2B-containing NMDARs, thereby facilitating induction of Long-term potentiation by short bursts of high-frequency stimulation. We describe novel roles of EAAC1 in regulating glutamate diffusion and propose that NMDARs at different subsynaptic locations can make distinct contributions to the regulation of synaptic strength.
Presenilin transgenic mice as models of Alzheimer's disease.
Brain Struct Funct. 2009 Nov 18;
Elder GA, Gama Sosa MA, De Gasperi R, Dickstein DL, Hof PR
Mutations in presenilin-1 (PS1) and presenilin-2 (PS2) cause familial Alzheimer's disease (FAD). Presenilins influence multiple molecular pathways and are best known for their role in the gamma-secretase cleavage of type I transmembrane proteins including the amyloid precursor protein (APP). PS1 and PS2 FAD mutant transgenic mice have been generated using a variety of promoters. PS1-associated FAD mutations have also been knocked into the endogenous mouse gene. PS FAD mutant mice consistently show elevations of Abeta42 with little if any effect on Abeta40. When crossed with plaque forming APP FAD mutant lines, the PS1 FAD mutants cause earlier and more extensive plaque deposition. Although single transgenic PS1 or PS2 mice do not form plaques, they exhibit a number of pathological features including age-related neuronal and synaptic loss as well as vascular pathology. They also exhibit increased susceptibility to excitotoxic injury most likely on the basis of exaggerated calcium release from the endoplasmic reticulum. Electrophysiologically Long-term potentiation in the hippocampus is increased in young PS1 FAD mutant mice but this effect appears to be lost with aging. In most studies neurogenesis in the adult hippocampus is also impaired by PS1 FAD mutants. Mice in which PS1 has been conditionally knocked out in adult forebrain on a PS2 null background (PS1/2 cDKO) develop a striking neurodegeneration that mimics AD neuropathology in being associated with neuronal and synaptic loss, astrogliosis and hyperphosphorylation of tau, although it is not accompanied by plaque deposits. The relevance of PS transgenic mice as models of AD is discussed.
Exp Brain Res. 2009 Nov 17;
Kamal A, Van der Harst JE, Kapteijn CM, Baars AJ, Spruijt BM, Ramakers GM
Chronic stress causes insensitivity to rewards (anhedonia) in rats, reflected by the absence of anticipatory behavior for a sucrose-reward, which can be reversed by antidepressant treatment or repeated announced transfer to an enriched cage. It was, however, not clear whether the highly rewarding properties of the enriched cage alone caused this reversal or whether the anticipation of this reward as such had an additional effect. Therefore, the present study compared the consequences of the announcement of a reward to the mere effect of a reward alone with respect to their efficacy to counteract the consequences of chronic stress. Two forms of synaptic plasticity, Long-term potentiation and Long-term depression were investigated in area CA1 of the hippocampus. This was done in socially stressed rats (induced by defeat and subsequent Long-term individual housing), socially stressed rats that received a reward (short-term enriched housing) and socially stressed rats to which this reward was announced by means of a stimulus that was repeatedly paired to the reward. The results were compared to corresponding control rats. We show that announcement of enriched housing appeared to have had an additional effect compared to the enriched housing per se as indicated by a significant higher amount of LTP. In conclusion, announced short-term enriched housing has a high and long-lasting counteracting efficacy on stress-induced alterations of hippocampal synaptic plasticity. This information is important for counteracting the consequences of chronic stress in both human and captive rats.
Nogo receptor 1 regulates formation of lasting memories.
Proc Natl Acad Sci U S A. 2009 Nov 13;
Karlén A, Karlsson TE, Mattsson A, Lundströmer K, Codeluppi S, Pham TM, Bäckman CM, Ogren SO, Aberg E, Hoffman AF, Sherling MA, Lupica CR, Hoffer BJ, Spenger C, Josephson A, Brené S, Olson L
Formation of lasting memories is believed to rely on structural alterations at the synaptic level. We had found that increased neuronal activity down-regulates Nogo receptor-1 (NgR1) in brain regions linked to memory formation and storage, and postulated this to be required for formation of lasting memories. We now show that mice with inducible overexpression of NgR1 in forebrain neurons have normal Long-term potentiation and normal 24-h memory, but severely impaired month-long memory in both passive avoidance and swim maze tests. Blocking transgene expression normalizes these memory impairments. Nogo, Lingo-1, Troy, endogenous NgR1, and BDNF mRNA expression levels were not altered by transgene expression, suggesting that the impaired ability to form lasting memories is directly coupled to inability to down-regulate NgR1. Regulation of NgR1 may therefore serve as a key regulator of memory consolidation. Understanding the molecular underpinnings of synaptic rearrangements that carry lasting memories may facilitate development of treatments for memory dysfunction.
Sleep Fragmentation reduces Hippocampal CA1 Pyramidal Cell Excitability and Response to Adenosine.
Neurosci Lett. 2009 Nov 12;
Tartar JL, McKenna JT, Ward CP, McCarley RW, Strecker RE, Brown RE
Sleep fragmentation (SF) impairs the restorative/cognitive benefits of sleep via as yet unidentified alterations in neural physiology. Previously, we found that hippocampal synaptic plasticity and spatial learning are impaired in a rat model of SF which utilizes a treadmill to awaken the animals every 2min, mimicking the frequency of awakenings observed in human sleep apnea patients. Here, we investigated the cellular mechanisms responsible for these effects, using whole-cell patch-clamp recordings. 24h of SF decreased the excitability of hippocampal CA1 pyramidal neurons via decreased input resistance, without alterations in other intrinsic membrane or action potential properties (when compared to cage controls, or to exercise controls that experienced the same total amount of treadmill movement as SF rats). Contrary to our initial prediction, the hyperpolarizing response to bath applied adenosine (30muM) was reduced in the CA1 neurons of SF treated rats. Our initial prediction was based on evidence that sleep loss upregulates cortical adenosine A1 receptors; however, the present findings are consistent with a very recent report that hippocampal A1 receptors are not elevated by sleep loss. Thus, increased adenosinergic inhibition is unlikely to be responsible for reduced hippocampal Long-term potentiation in SF rats. Instead, the reduced excitability of CA1 pyramidal neurons observed here may contribute to the loss of hippocampal Long-term potentiation and hippocampus-dependent cognitive impairments associated with sleep disruption.
AMPA receptor incorporation into synapses during LTP: the role of lateral movement and exocytosis.
Neuron. 2009 Nov 12; 64(3): 381-90
Makino H, Malinow R
The regulated trafficking of AMPA receptors (AMPARs) to synapses is thought to underlie the enhanced transmission in Long-term potentiation (LTP), a cellular model of memory. However, there is controversy regarding the nonsynaptic site, either on the surface or intracellularly, from which AMPARs move into synapses during LTP. Using recombinant surface-fluorescent receptors in organotypic rat hippocampal slices, we show that the majority of AMPARs incorporated into synapses during LTP is from lateral diffusion of spine surface receptors containing GluR1, an AMPAR subunit. Following synaptic potentiation, AMPARs in intracellular pools containing GluR1 are driven to the surface primarily on dendrites. These exocytosed receptors likely serve to replenish the local extrasynaptic pool available for subsequent bouts of plasticity. These results clarify the role of intracellular and surface AMPARs during synaptic plasticity.
Adult neurogenesis modulates the hippocampus-dependent period of associative fear memory.
Cell. 2009 Nov 13; 139(4): 814-27
Kitamura T, Saitoh Y, Takashima N, Murayama A, Niibori Y, Ageta H, Sekiguchi M, Sugiyama H, Inokuchi K
Acquired memory initially depends on the hippocampus (HPC) for the process of cortical permanent memory formation. The mechanisms through which memory becomes progressively independent from the HPC remain unknown. In the HPC, adult neurogenesis has been described in many mammalian species, even at old ages. Using two mouse models in which hippocampal neurogenesis is physically or genetically suppressed, we show that decreased neurogenesis is accompanied by a prolonged HPC-dependent period of associative fear memory. Inversely, enhanced neurogenesis by voluntary exercise sped up the decay rate of HPC dependency of memory, without loss of memory. Consistently, decreased neurogenesis facilitated the long-lasting maintenance of rat hippocampal Long-term potentiation in vivo. These independent lines of evidence strongly suggest that the level of hippocampal neurogenesis play a role in determination of the HPC-dependent period of memory in adult rodents. These observations provide a framework for understanding the mechanisms of the hippocampal-cortical complementary learning systems.
J Neurochem. 2009 Nov 11;
Ploski JE, Park KW, Ping J, Monsey MS, Schafe GE
Abstract Most recent studies aimed at defining the cellular and molecular mechanisms of Pavlovian fear conditioning have focused on protein kinase signaling pathways and the transcription factor CREB that promote fear memory consolidation in the lateral nucleus of the amygdala (LA). Despite this progress, there still remains a paucity of information regarding the genes downstream of CREB that are required for long term fear memory formation in the LA. We have adopted a strategy of using microarray technology to initially identify genes induced within the dentate gyrus following in vivo Long-term potentiation (LTP) followed by analysis of whether these same genes are also regulated by fear conditioning within the LA. In the present study, we first identified 34 plasticity-associated genes that are induced within thirty minutes following LTP induction utilizing a combination of DNA microarray, qRT-PCR, and in situ hybridization. To determine whether these genes are also induced in the LA following Pavlovian fear conditioning, we next exposed rats to an auditory fear conditioning protocol or to control conditions that do not support fear learning followed by qRT-PCR on mRNA from microdissected LA samples. Finally, we asked whether identified genes induced by fear learning in the LA are downstream of the ERK/MAPK signaling cascade. Collectively, our findings reveal a comprehensive list of genes that represent the first wave of transcription following both LTP induction and fear conditioning that largely belong to a class of genes referred to as "neuronal activity dependent genes" that are likely calcium, ERK/MAPK, and CREB-dependent.
J Neurochem. 2009 Nov 11;
Fan N, Yang H, Zhang J, Chen C
Abstract Chronic use of marijuana impairs synaptic plasticity and cognitive function. However, the molecular mechanisms by which marijuana alters Long-term synaptic plasticity are largely unknown. Here we show that repeated in vivo exposures to Delta9-THC for 7 consecutive days significantly impaired hippocampal Long-term potentiation (LTP) of excitatory glutamatergic synaptic transmission. The Delta9-THC exposure-induced decrease in LTP was prevented by pharmacological inhibition or deletion of the CB1 receptor. To determine the molecular mechanisms underlying Delta9-THC-altered LTP, we targeted expression and function of the glutamate receptors and phosphorylation status of cAMP response element binding protein (CREB). Chronic in vivo exposure to Delta9-THC produced CB1 receptor-dependent decreases in expression of hippocampal glutamate receptor subunits GluR1, NR2A and NR2B, the ratio of AMPA/NMDA receptor-gated currents, and phosphorylation of CREB. Our results suggest that reduced expression and function of the glutamate receptor subunits and phosphorylation of CREB may underlie the impaired Long-term synaptic plasticity induced by repeated in vivo exposure to Delta9-THC.
Modulation of synaptic plasticity by brain estrogen in the hippocampus.
Biochim Biophys Acta. 2009 Nov 10;
Mukai H, Kimoto T, Hojo Y, Kawato S, Murakami G, Higo S, Hatanaka Y, Ogiue-Ikeda M
The hippocampus is a center for learning and memory as well as a target of Alzheimer's disease in aged humans. Synaptic modulation by estrogen is essential to understand the molecular mechanisms of estrogen replacement therapy. Because the local synthesis of estrogen occurs in the hippocampus of both sexes, in addition to the estrogen supply from the gonads, its functions are attracting much attention. Hippocampal estrogen modulates memory-related synaptic plasticity not only slowly but also rapidly. Slow actions of 17beta-estradiol (17beta-E2) occur via classical nuclear receptors (ERalpha or ERbeta), while rapid E2 actions occur via synapse-localized ERalpha or ERbeta. Elevation or decrease of the E2 concentration changes rapidly the density and morphology of spines in CA1-CA3 neurons. ERalpha, but not ERbeta, drives this enhancement/suppression of spinogenesis. Kinase networks are involved downstream of ERalpha. The Long-term depression but not the Long-term potentiation is modulated rapidly by changes of E2 level. Determination of the E2 concentration in the hippocampus is enabled by mass-spectrometry in combination with derivatization methods. The E2 level in the hippocampus is as high as approx. 8 nM for the male and 0.5-2 nM for the female, which is much higher than that in circulation. Therefore, hippocampus-derived E2 plays a major role in modulation of synaptic plasticity. Many hippocampal slice experiments measure the restorative effects of E2 by supplementation of E2 to E2-depleted slices. Accordingly, isolated slice experiments can be used as in vitro models of in vivo estrogen replacement therapy for ovariectomized female animals with depleted circulating estrogen.
Biochem Soc Trans. 2009 Dec; 37(Pt 6): 1394-8
Shen G, Mohamed MS, Das P, Tietz EI
Long-term BZ (benzodiazepine) anxiolytic therapy increases the risk of physical dependence manifested as withdrawal anxiety. BZ-induced potentiation of GABA(A)R (gamma-aminobutyric acid type-A receptor) function by 1-week oral administration of FZP (flurazepam) bi-directionally modulates excitatory glutamatergic synaptic transmission in hippocampal CA1 neurons during drug withdrawal. Previous electrophysiological studies on acutely isolated and intact CA1 neurons, as well as immunofluorescence and post-embedding immunogold electron microscopy studies, suggest increased synaptic insertion of GluR (glutamate receptor) 2-lacking AMPARs (alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors) in 2-day FZP-withdrawn rats. Preliminary studies indicated a similar increase in GluR1, then phospho-Ser(831)-GluR1, as well as CaMKIIalpha (Ca(2+)/calmodulin-dependent protein kinase IIalpha), but not phospho-Thr(286)-CaMKII levels at the same time point. In our studies, whole-cell recordings in hippocampal slices revealed that AMPAR mEPSC [miniature EPSC (excitatory postsynaptic current)] amplitude was increased in 1-day FZP-withdrawn rats followed by an increase in estimated single-channel conductance in 2-day-FZP-withdrawn rats. Enhanced conductance was no longer observed in slices pre-incubated for 2 h in the CaMKII inhibitor KN-93, but not the inactive analogue KN-92. To evaluate whether CaMKII-mediated AMPA potentiation could occlude LTP (Long-term potentiation), LTP was induced by TBS (theta burst stimulation) and recorded using whole-cell and extracellular techniques. LTP was induced in both groups, but only maintained for <15 min in 2-day FZP-withdrawn rats. LTP was fully restored after 7-day withdrawal. Despite the lack of LTP maintenance, impairment of object recognition, place and context was not observed in 2-day-FZP-withdrawn rats. Since L-VGCC (L-type voltage-gated calcium channel) current density was doubled on drug withdrawal and up to 2 days, Ca(2+) entry through L-VGCCs and perhaps subsequently through Ca(2+)-permeable AMPARs are proposed to be responsible for enhanced CaMKIIalpha levels and AMPAR potentiation. Mechanisms associated with several different models of activity-dependent plasticity may underlie BZ physical dependence.
Regulation of NMDA receptor Ca(2+) signalling and synaptic plasticity.
Biochem Soc Trans. 2009 Dec; 37(Pt 6): 1369-74
Lau CG, Takeuchi K, Rodenas-Ruano A, Takayasu Y, Murphy J, Bennett MV, Zukin RS
NMDARs (N-methyl-D-aspartate receptors) are critical for synaptic function throughout the CNS (central nervous system). NMDAR-mediated Ca(2+) influx is implicated in neuronal differentiation, neuronal migration, synaptogenesis, structural remodelling, long-lasting forms of synaptic plasticity and higher cognitive functions. NMDAR-mediated Ca(2+) signalling in dendritic spines is not static, but can be remodelled in a cell- and synapse-specific manner by NMDAR subunit composition, protein kinases and neuronal activity during development and in response to sensory experience. Recent evidence indicates that Ca(2+) permeability of neuronal NMDARs, NMDAR-mediated Ca(2+) signalling in spines and induction of NMDAR-dependent LTP (Long-term potentiation) at hippocampal Schaffer collateral-CA1 synapses are under control of the cAMP/PKA (protein kinase A) signalling cascade. Thus, by enhancing Ca(2+) influx through NMDARs in spines, PKA can regulate the induction of LTP. An emerging concept is that activity-dependent regulation of NMDAR-mediated Ca(2+) signalling by PKA and by extracellular signals that modulate cAMP or protein phosphatases at synaptic sites provides a dynamic and potentially powerful mechanism for bi-directional regulation of synaptic efficacy and remodelling.
Regulation of glutamate receptor trafficking by leptin.
Biochem Soc Trans. 2009 Dec; 37(Pt 6): 1364-8
Moult PR, Harvey J
It is well established that leptin is a circulating hormone that enters the brain and regulates food intake and body weight via its hypothalamic actions. However, it is also known that leptin receptors are widely expressed in the CNS (central nervous system), and evidence is accumulating that leptin modulates many neuronal functions. In particular, recent studies have indicated that leptin plays an important role in the regulation of hippocampal synaptic plasticity. Indeed leptin-insensitive rodents display impairments in hippocampal synaptic plasticity and defects in spatial memory tasks. We have also shown that leptin facilitates the induction of hippocampal LTP (Long-term potentiation) via enhancing NMDA (N-methyl-D-aspartate) receptor function and that leptin has the ability to evoke a novel form of NMDA receptor-dependent LTD (Long-term depression). In addition, leptin promotes rapid alterations in hippocampal dendritic morphology and synaptic density, which are likely to contribute to the effects of this hormone on excitatory synaptic strength. Recent studies have demonstrated that trafficking of AMPA (alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid) receptors is pivotal for activity-dependent hippocampal synaptic plasticity. However, little is known about how AMPA receptor trafficking processes are regulated by hormonal systems. In the present paper, we discuss evidence that leptin rapidly alters the trafficking of AMPA receptors to and away from hippocampal CA1 synapses. The impact of these leptin-driven changes on hippocampal excitatory synaptic function are discussed.
Neuronal calcium sensors and synaptic plasticity.
Biochem Soc Trans. 2009 Dec; 37(Pt 6): 1359-63
Amici M, Doherty A, Jo J, Jane D, Cho K, Collingridge G, Dargan S
Calcium entry plays a major role in the induction of several forms of synaptic plasticity in different areas of the central nervous system. The spatiotemporal aspects of these calcium signals can determine the type of synaptic plasticity induced, e.g. LTP (Long-term potentiation) or LTD (Long-term depression). A vast amount of research has been conducted to identify the molecular and cellular signalling pathways underlying LTP and LTD, but many components remain to be identified. Calcium sensor proteins are thought to play an essential role in regulating the initial part of synaptic plasticity signalling pathways. However, there is still a significant gap in knowledge, and it is only recently that evidence for the importance of members of the NCS (neuronal calcium sensor) protein family has started to emerge. The present minireview aims to bring together evidence supporting a role for NCS proteins in plasticity, focusing on emerging roles of NCS-1 and hippocalcin.
J Neurosci. 2009 Nov 11; 29(45): 14086-99
Xu TX, Sotnikova TD, Liang C, Zhang J, Jung JU, Spealman RD, Gainetdinov RR, Yao WD
Dopamine (DA) plays crucial roles in the cognitive functioning of the prefrontal cortex (PFC), which, to a large degree, depends on lasting neural traces formed in prefrontal networks. The establishment of these permanent traces requires changes in cortical synaptic efficacy. DA, via the D(1)-class receptors, is thought to gate or facilitate synaptic plasticity in the PFC, with little role recognized for the D(2)-class receptors. Here we show that, when significantly elevated, DA erodes, rather than facilitates, the induction of Long-term potentiation (LTP) in the PFC by acting at the far less abundant cortical D(2)-class receptors through a dominant coupling to the protein phosphatase 1 (PP1) activity in postsynaptic neurons. In mice with persistently elevated extracellular DA, resulting from inactivation of the DA transporter (DAT) gene, LTP in layer V PFC pyramidal neurons cannot be established, regardless of induction protocols. Acute increase of dopaminergic transmission by DAT blockers or overstimulation of D(2) receptors in normal mice have similar LTP shutoff effects. LTP in mutant mice can be rescued by a single in vivo administration of D(2)-class antagonists. Suppression of postsynaptic PP1 mimics and occludes the D(2)-mediated rescue of LTP in mutant mice and prevents the acute erosion of LTP by D(2) agonists in normal mice. Our studies reveal a mechanistically unique heterosynaptic PP1 gate that is constitutively driven by background DA to influence LTP induction. By blocking prefrontal synaptic plasticity, excessive DA may prevent storage of lasting memory traces in PFC networks and impair executive functions.
J Neurophysiol. 2009 Nov 11;
Lee HK, Takamiya K, He K, Song L, Huganir RL
Activity-dependent changes in excitatory synaptic transmission in the central nervous system have been shown to depend on the regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs). In particular, several lines of evidence suggest that reversible phosphorylation of AMPAR subunit GluR1 (also referred to as GluA1 or GluR-A) plays a role in Long-term potentiation (LTP) and Long-term depression (LTD). We have reported previously that regulation of serines (S) 831 and 845 on the GluR1 subunit may play critical roles in bidirectional synaptic plasticity in the Schaffer collateral inputs to CA1. Specifically, gene knockin mice lacking both S831 and S845 phosphorylation sites ("double phosphomutants"), where both serine residues were replaced by alanines (A), showed a faster decaying LTP and a deficit in LTD. In order to determine which of the two phosphorylation sites were responsible for the phenotype, we have now generated two lines of gene knockin mice, one that specifically lacks S831 (S831A mutants) and another that lacks only S845 (S845A mutants). We found that S831A mutants display normal LTP and LTD, while S845A mutants show a specific deficit in LTD. Taken together with our previous results from the "double phosphomutants", our data suggest that S831 or S845 alone may support LTP, while S845 site is critical for LTD expression.
J Neurophysiol. 2009 Nov 11;
Lee KY, Chung K, Chung JM
Recent studies suggest that reactive oxygen species (ROS) are functional messenger molecules in central sensitization, an underlying mechanism of persistent pain. Since spinal cord long term potentiation (LTP) is the electrophysiological basis of central sensitization, this study investigates the effects of the increased or decreased spinal ROS levels on spinal cord LTP. Spinal cord LTP is induced by either brief, high frequency stimulation (HFS) of a dorsal root at C-fiber intensity or superfusion of a ROS donor, tert-butyl hydroperoxide (t-BOOH), onto rat spinal cord slice preparations. Field excitatory postsynaptic potentials (fEPSPs) evoked by dorsal root stimulations with either Abeta- or C-fiber intensity are recorded from the superficial dorsal horn. HFS significantly increases the slope of both Abeta- and C-fiber evoked fEPSPs, thus suggesting LTP development. The induction, not the maintenance, of HFS-induced LTP is blocked by a NMDA receptor antagonist, D-AP5. Both the induction and maintenance of LTP of Abeta-fiber evoked fEPSPs are inhibited by a ROS scavenger, either PBN (N-tert-butyl-alpha-phenylnitrone) or TEMPOL (4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl). A ROS donor, t-BOOH, induced LTP is inhibited by PBN but not by D-AP5. Furthermore, HFS-induced LTP and t-BOOH-induced LTP occlude each other. The data suggest that elevated ROS is a downstream event of NMDA receptor activation and an essential step for potentiation of synaptic excitability in the spinal dorsal horn.
Genes Brain Behav. 2009 Sep 22;
Porro F, Rosato-Siri M, Leone E, Costessi L, Iaconcig A, Tongiorgi E, Muro AF
Adducins are a family of proteins found in cytoskeleton junctional complexes, which bind and regulate actin filaments and actin-spectrin complexes. In brain, adducin is expressed at high levels and is identified as a constituent of synaptic structures, such as dendritic spines and growth cones of neurons. Adducin-induced changes in dendritic spines are involved in activity-dependent synaptic plasticity processes associated with learning and memory, but the mechanisms underlying these functions remain to be elucidated. Here, beta-adducin knockout (KO) mice were used to obtain a deeper insight into the role of adducin in these processes. We showed that beta-adducin KO mice showed behavioral, motor coordination and learning deficits together with an altered expression and/or phosphorylation levels of alpha-adducin and gamma-adducin. We found that beta-adducin KO mice exhibited deficits in learning and motor performances associated with an impairment of Long-term potentiation (LTP) and Long-term depression (LTD) in the hippocampus. These effects were accompanied by a decrease in phosphorylation of adducin, a reduction in alpha-adducin expression levels and upregulation of gamma-adducin in hippocampus, cerebellum and neocortex of mutant mice. In addition, we found that the mRNA encoding beta-adducin is also located in dendrites, where it may participate in the fine modulation of LTP and LTD. These results strongly suggest coordinated expression and phosphorylation of adducin subunits as a key mechanism underlying synaptic plasticity, motor coordination performance and learning behaviors.
PLoS One. 2009; 4(11): e7690
Antonova I, Lu FM, Zablow L, Udo H, Hawkins RD
Long-term potentiation in hippocampal neurons has stages that correspond to the stages of learning and memory. Early-phase (10-30 min) potentiation is accompanied by rapid increases in clusters or puncta of presynaptic and postsynaptic proteins, which depend on actin polymerization but not on protein synthesis. We have now examined changes in pre- and postsynaptic puncta and structures during glutamate-induced late-phase (3 hr) potentiation in cultured hippocampal neurons. We find that (1) the potentiation is accompanied by long-lasting maintenance of the increases in puncta, which depends on protein synthesis, (2) most of the puncta and synaptic structures are very dynamic, continually assembling and disassembling at sites that are more stable than the puncta or structures themselves, (3) the increase in presynaptic puncta appears to be due to both rapid and more gradual increases in the number of sites where the puncta may form, and also to the stabilization of existing puncta, (4) under control conditions, puncta of postsynaptic proteins behave similarly to puncta of presynaptic proteins and share sites with them, and (5) the increase in presynaptic puncta is accompanied by a similar increase in presumably presynaptic structures, which may form at distinct as well as shared sites. The new sites could contribute to the transition between the early and late phase mechanisms of plasticity by serving as seeds for the formation and maintenance of new synapses, thus acting as local "tags" for protein synthesis-dependent synaptic growth during late-phase plasticity.
Biol Psychiatry. 2009 Nov 4;
Marchetti C, Tafi E, Middei S, Rubinacci MA, Restivo L, Ammassari-Teule M, Marie H
BACKGROUND: Antidepressants (AD) need to be chronically administered (weeks to months) to provide beneficial effects. Evidence suggests that combined administration of inhibitors of monoamine reuptake and phosphodiesterase type 4 allows a highly effective therapeutic action. Also, this coadministration more rapidly boosts the cyclic adenosine monophosphate (cAMP) pathway, which is normally activated during chronic treatment of single compounds. Little is known, however, about how this augmentation therapy affects the core mechanism of glutamatergic plasticity. We therefore investigated how in vivo combinational subchronic rolipram and imipramine (scRI) treatment affects depressive behavior, cAMP-dependent transcription, and glutamatergic transmission in the hippocampus, a region critically implicated in depression. METHODS: Antidepressant properties of scRI were investigated through the forced swim test. Changes in cAMP-dependent transcription and synaptic transmission of CA1 pyramidal cells were explored with green fluorescent protein, enzyme-linked immunosorbent assay, electrophysiology recordings, and Golgi-Cox staining. RESULTS: We demonstrate that scRI displays robust antidepressant properties compared with single-drug treatments and increases hippocampal c-Fos expression and brain-derived neurotrophic factor protein levels. These effects are accompanied by a specific increase in alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and N-methyl-D-aspartate receptors in already existing synapses. Finally, both acute and subchronic treatments led to enhancement of Long-term potentiation but differently affected spine density and morphology, with scRI administration specifically resulting in a large increase in stubby spines. CONCLUSIONS: We conclude that scRI is highly effective in providing antidepressive effects, including the hippocampal transcriptional alterations normally observed with longer single-drug treatments. Furthermore, we identified scRI-induced modifications in glutamatergic transmission that probably underlie the beneficial action of this combinational therapy.